Maravai Lifesciences Holdings Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$65,200	$73,400	$64,179	$74,141
Gross Profit	28,374	35,129	18,975	38,433
EBITDA	-147,971	9,559	2,208	684,566
EBIT	-162,010	-4,988	-11,545	671,586
Net Income	-99,038	-7,585	-12,078	-105,959
Net Change In Cash	65,200	73,400	64,179	74,141
Free Cash Flow	4,545	7,881	-14,132	-9,009
Cash	578,157	573,171	561,691	574,962
Basic Shares	141,555	135,842	132,333	132,139

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$288,945	$883,001	$799,240	$284,098
Gross Profit	140,202	714,044	658,679	204,449
EBITDA	712,409	609,989	585,777	138,273
EBIT	663,628	571,886	561,025	112,436
Net Income	-119,029	490,663	469,250	76,888
Net Change In Cash	288,945	883,001	799,240	284,098
Cost of Revenue			315,176
Free Cash Flow	60,671	518,887	353,720	126,779
Cash	574,962	632,138	551,272	236,184
Basic Shares	131,919	255,323	257,803	96,646